Company intelligence / Profile preview

DEOXY

Munich, Bavaria, Germany

Ownership: Private
Employees: ~20
Development stage: Other

Overview

DEOXY is a Munich-based biotechnology company that has developed a breakthrough platform for automated, high-throughput single-cell analysis. The company's technology enables the quantification of gene expression at the single-cell level directly within intact tissue samples or cell cultures. By combining advanced microfluidics with DNA-based molecular barcoding, DEOXY provides researchers and clinicians with high-resolution spatial transcriptomics data. This technology is primarily used to understand tumor heterogeneity and improve precision medicine in oncology.

Therapeutic areas: Oncology
Modalities: Spatial transcriptomicsSingle-cell analysis platform
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on DEOXY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEOXY.

Explore the full profile